P

Pharvaris

73 employees

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Medicinal Chemistry
Biotechnology
Health Care
Hereditary Angioedema
Pharmaceutical
Drug Development
Drug Discovery
Life Science
Pharmaceuticals

Date founded

2015

Funding rounds raised

Total raised

$80M

from 15 investors over 15 rounds

P

Pharvaris raised $70M on June 20, 2023

Investors: venBio Partners, General Atlantic and Foresite Capital

P

Pharvaris raised $80M on November 18, 2020

Investors: General Atlantic, Viking Global Investors, venBio Partners, Foresite Capital and Venrock

P

Pharvaris raised $66M on September 10, 2019

Investors: Venrock, Idinvest Partners, venBio Partners, Foresite Capital and EQT Life Sciences

P

Pharvaris raised $16M on January 1, 2016

Investors: EQT Life Sciences and Idinvest Partners

FAQ